Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction.
Francesco GiallauriaGiuseppe VitaleMario PacileoAnna Di LorenzoAlessandro OlivieroFrancesco PassaroRoberta CalceAlessandro ParlatoCrescenzo TestaGiuseppe D'AmbrosioGiuseppe RomanoFrancesco ClemenzaSilvia SarulloElio VenturiniMarco GentileCinzia NugaraGabriella IannuzzoAntonello D'AndreaCarlo VigoritoFilippo Maria SarulloPublished in: Journal of clinical medicine (2020)
In HFrEF patients, S/V therapy improves autonomic function, functional capacity, and ventilation. Whether these findings might translate into beneficial effects on prognosis and outcome remains to be elucidated.